Carbidopa and levodopa enteral and Lixisenatide Subcutaneous
Determining the interaction of Carbidopa and levodopa enteral and Lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and levodopa enteral-Lixtraxen Injection
- Carbidopa and levodopa enteral-LMD
- Carbidopa and levodopa enteral-LMD Injection
- Carbidopa and levodopa enteral-LMX 4 Topical application
- Carbidopa and levodopa enteral-LMX 5
- Carbidopa and levodopa enteral-LMX 5 Topical application
- Lixisenatide Subcutaneous-Carbidopa and Levodopa Enteral Suspension
- Lixisenatide Subcutaneous-Carbidopa and Levodopa Extended-Release Capsules
- Lixisenatide Subcutaneous-Carbidopa and Levodopa Extended-Release Tablets
- Lixisenatide Subcutaneous-Carbidopa and Levodopa ODT
- Lixisenatide Subcutaneous-Carbidopa and Levodopa Orally Disintegrating Tablets
- Lixisenatide Subcutaneous-Carbidopa and levodopa Route Not Applicable